Li, F.; Gong, H.; Jia, X.; Gao, C.; Jia, P.; Zhao, X.; Chen, W.; Wang, L.; Xue, N.
RNAi Screen Identifies AXL Inhibition Combined with Cannabinoid WIN55212-2 as a Potential Strategy for Cancer Treatment. Pharmaceuticals 2024, 17, 1465.
https://doi.org/10.3390/ph17111465
AMA Style
Li F, Gong H, Jia X, Gao C, Jia P, Zhao X, Chen W, Wang L, Xue N.
RNAi Screen Identifies AXL Inhibition Combined with Cannabinoid WIN55212-2 as a Potential Strategy for Cancer Treatment. Pharmaceuticals. 2024; 17(11):1465.
https://doi.org/10.3390/ph17111465
Chicago/Turabian Style
Li, Feifei, Hang Gong, Xinfei Jia, Chang Gao, Peng Jia, Xin Zhao, Wenxia Chen, Lili Wang, and Nina Xue.
2024. "RNAi Screen Identifies AXL Inhibition Combined with Cannabinoid WIN55212-2 as a Potential Strategy for Cancer Treatment" Pharmaceuticals 17, no. 11: 1465.
https://doi.org/10.3390/ph17111465
APA Style
Li, F., Gong, H., Jia, X., Gao, C., Jia, P., Zhao, X., Chen, W., Wang, L., & Xue, N.
(2024). RNAi Screen Identifies AXL Inhibition Combined with Cannabinoid WIN55212-2 as a Potential Strategy for Cancer Treatment. Pharmaceuticals, 17(11), 1465.
https://doi.org/10.3390/ph17111465